Menu
Watch this space! The Bright Blog features our latest industry insights, team happenings, news, and the success stories where we helped our clients shine.
by Andrea Fenton Abbs
In a recent conversation with a new business contact, I shared what made Bright special, why we’re so optimistic about our future and why we excel at culture, employee retention, and repeat business. It was an easy conversation to have because it was authentic, and afterward I realized I had touched on many of the points in my “Building a Sustainable Bright Future” blog from January 2023. I thought it would be fun in this month’s blog to check back on those points and recap our best year ever!
A medical device company’s post-approval study launch had been stalled for so long that continued FDA approval for their product was at risk. Furthermore, the company’s planned post-approval study, which aimed to monitor the long–term safety of their medical device, required a lengthy, five-year follow-up – and thus a large consumption of resources. Bright Research was brought in to help.
Bright’s Scott Brown and Dylan Lukes are back from #ISC2024, the world’s premier conference for stroke research and treatment. These two are passionate about clinical research and improving patient lives through statistically meaningful clinical studies.
When you partner with experienced and capable investigators and research teams, you’ll be able to execute
In celebration of Earth Day and the sense of renewal that invigorates us each spring, Bright
The randomized controlled trial (RCT) is the gold standard of clinical research, providing the highest level
What did the case report forms say to the research coordinator? You complete me. Valentine’s Day mushiness aside, case report
Most leadership teams would agree that it is better to meet the timeline of a well-thought-out
We’re taking time to reflect on the blog topics we shared in 2021, the experience we
When a clinical study will be used to support an FDA market authorization application, it’s likely
It may seem counterintuitive that collecting too much data is a common pitfall in clinical study
Every medical device clinical study has endpoints, although they may be called something else, such as
As I prepare to retire from my long and rewarding career in clinical research, I’ve reflected on key learnings to share with my amazing BRIGHT
Avoid costly surprises during the study or regulatory application process.
Work-life balance. Mindfulness. Self-care. Is there a fly in here, or just the sound of buzzwords?
